معرفی
Dr. Atul Gupta is a medical researcher with significant contributions to respiratory medicine, particularly focusing on pediatric asthma, sickle cell disease, and post-COVID-19 recovery. His research profile shows strong engagement with the UK-based PHOSP-COVID Study Collaborative Group and other major research initiatives examining long-term health outcomes following SARS-CoV-2 infection. With 790+ citations and 25 research outputs, his work spans clinical trials, observational studies, and systematic reviews addressing critical gaps in respiratory care.
Dr. Gupta's research interests center on understanding and improving respiratory outcomes in vulnerable populations, particularly children with chronic conditions. His fingerprint reveals deep expertise in sickle-cell disease (100%), asthma (80%), oxygen therapy (50%), dyspnea (50%), and COVID-19 (50%). He has made notable contributions to understanding health disparities, particularly examining how ethnicity influences recruitment into clinical trials for conditions like Parkinson's disease and pediatric asthma. His work consistently addresses practical clinical challenges while highlighting systemic issues related to health equity and access to care.
Analysis of his recent publications reveals a strong focus on biologic therapies for severe asthma in children, addressing both efficacy and real-world implementation challenges. His research spans from basic science investigations of respiratory syncytial virus to clinical trials of novel treatments like tezepelumab and mepolizumab. A distinctive thread throughout his work is attention to health disparities, particularly examining how skin pigmentation affects pulse oximetry accuracy and how ethnicity influences clinical trial participation.
Dr. Gupta has been actively involved in major collaborative efforts including the PHOSP-COVID study, which has generated significant media attention with coverage by 73 news outlets and discussion across multiple social media platforms. His work on post-COVID dyspnea has been particularly influential, appearing in high-impact journals like The Lancet Respiratory Medicine and receiving substantial academic attention.
His research demonstrates strong collaborative capacity, frequently working within large multi-center teams across the UK healthcare system. While specific grant funding isn't detailed in the available information, his participation in major studies like PHOSP-COVID (which received substantial UK government funding) indicates successful grant acquisition and management capabilities. His work bridges clinical practice and research, with clear translation of findings to practical healthcare applications.
Dr. Gupta's research network extends across multiple institutions focused on respiratory medicine and pediatric care. His work on the PHOSP-COVID study connects him with a broad consortium of UK researchers examining long-term COVID outcomes, while his asthma research links him with specialists in pediatric pulmonology and immunology. His interest in health equity suggests engagement with diverse community stakeholders to address systemic barriers in healthcare access.